Ginseng in Treatment of Fatigue in Multiple Sclerosis
キーワード
概要
説明
Multiple Sclerosis (MS) is one of the most common non-traumatic causes of disability in the world. It is a chronic inflammatory and demyelinating disorder of the Central Nervous System (CNS) which affects individuals in the productive ages and causes a large burden for years to come. Fatigue is a common complaint and one of the least understood symptoms of MS
日付
| 最終確認済み: | 09/30/2012 |
| 最初に提出された: | 10/18/2012 |
| 提出された推定登録数: | 10/21/2012 |
| 最初の投稿: | 10/22/2012 |
| 最終更新が送信されました: | 10/21/2012 |
| 最終更新日: | 10/22/2012 |
| 実際の研究開始日: | 11/30/2010 |
| 一次完了予定日: | 03/31/2011 |
| 研究完了予定日: | 03/31/2011 |
状態または病気
介入/治療
Drug: Ginseng
Drug: Placebo
段階
アームグループ
| 腕 | 介入/治療 |
|---|---|
| Active Comparator: Ginseng Ginseng, tablet, 250 mg, twice, 3 months | Drug: Ginseng it is kind of drug |
| Placebo Comparator: Placebo Placebo, tablet | Drug: Placebo it is placebo |
適格基準
| 研究の対象となる年齢 | 18 Years に 18 Years |
| 研究に適格な性別 | All |
| 健康なボランティアを受け入れる | はい |
| 基準 | Inclusion Criteria: - definite diagnosis of relapsing-remitting MS (RRMS) by the MacDonald criteria with a baseline of Expanded Disability Status Score (EDSS)of less than 5.0 Exclusion Criteria: - prior use of ginseng or any other tonic agents, glucocorticoids, warfarin, digoxin, aspirin, furosemide, caffeine, ephedra and anti-platelet agents within one month prior to enrollment; - Pregnancy or lactation; - history of renal failure; and, - lack of appropriate adherence to the study protocol. |
結果
主な結果の測定
1. Fatigue [at 3 months after treatment]
二次的な結果の測定
1. Quality Of Life [at 3 months after treatment]
